These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 3360680)
1. Impact of dosage regimens on the efficacy of antibiotics in the immunocompromised host. Bakker-Woudenberg IA; Roosendaal R J Antimicrob Chemother; 1988 Feb; 21(2):145-7. PubMed ID: 3360680 [No Abstract] [Full Text] [Related]
2. [Antibiotic therapy for the aged]. Igase M; Miki T Nihon Naika Gakkai Zasshi; 2006 Nov; 95(11):2193-6. PubMed ID: 17168391 [No Abstract] [Full Text] [Related]
4. Impact of the antibiotic dosage schedule on efficacy in experimental soft tissue infections. Gerber AU Scand J Infect Dis Suppl; 1990; 74():147-54. PubMed ID: 2097702 [TBL] [Abstract][Full Text] [Related]
5. When to Use Prophylactic Antibiotics in Neutropenic Patients. Zimmer A; Freifeld A Oncology (Williston Park); 2016 Sep; 30(9):838-40, 846. PubMed ID: 27633416 [No Abstract] [Full Text] [Related]
6. [The effect of the pharmacodynamics of different classes of antibacterial preparations on their dosage regimens]. Strachunskiĭ AS; Mukonin AA Antibiot Khimioter; 2000; 45(4):40-4. PubMed ID: 10851650 [No Abstract] [Full Text] [Related]
7. New era for orally administered antibiotics: use of sequential parenteral-oral antibiotic therapy for serious infectious diseases of infants and children. McCracken GH Pediatr Infect Dis J; 1987 Oct; 6(10):951-3. PubMed ID: 3320925 [TBL] [Abstract][Full Text] [Related]
8. [Guidelines for use of antibiotics in burn patient at the acute phase--long text. Société française d'étude et de traitement des brûlures]. Société française d'étude et de traitement des brûlures (SFETB) Ann Fr Anesth Reanim; 2009 Mar; 28(3):265-74. PubMed ID: 19324514 [No Abstract] [Full Text] [Related]
9. Clinical infections, antibiotics and immunosuppression: a puzzling relationship. Miller TE; North DK Am J Med; 1981 Sep; 71(3):334-6. PubMed ID: 6456663 [No Abstract] [Full Text] [Related]
10. Human pharmacokinetics and rationale for once-weekly dosing of dalbavancin, a semi-synthetic glycopeptide. Dorr MB; Jabes D; Cavaleri M; Dowell J; Mosconi G; Malabarba A; White RJ; Henkel TJ J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii25-30. PubMed ID: 15750034 [TBL] [Abstract][Full Text] [Related]
12. [Criteria for the correct use of antibiotics today]. Okolicsanyi L; Venuti M; Orlando R G Clin Med; 1987; 68(8-9):405-18. PubMed ID: 3319752 [No Abstract] [Full Text] [Related]
13. Immunocompromised animal models for the study of antibiotic combinations. Calandra T; Glauser MP Am J Med; 1986 May; 80(5C):45-52. PubMed ID: 3087166 [TBL] [Abstract][Full Text] [Related]